ISSN 3080-7611(Print)
ISSN 3080-762X(Online)
版权信息 · Copyright

     加入编委 / 副主编 / 同行评议专家
ISSN 3080-7611(Print)
ISSN 3080-762X(Online)

CODEN:ZLYABX
国际标准连续出版物标识符·全球唯一标识符
分配机构:美国化学文摘社(CAS)
DOI前缀:
https://doi.org/10.66106/zlyabx
国图集团 CIBTC
进口备案刊号:G015Z110

索引 检索 存档(Global Indexing)
本刊入选以下全球权威数据库,致力于研究成果的全球化无障碍传播。

CNKI(中国知网,申请中)
CNKI Open(中国知网·开放平台,申请中)
Wanfang Data(万方数据,中国,更新中)
CQVIP(维普期刊网,中国)
CQVIP(中文期刊服务平台,中国)
RCCSE(中国学术期刊目录,武汉大学)
CJWK(长江文库,中国)
BOOKAN(博看,中国)
591adb(中邮阅读·万章期刊,中国)
Baidu Scholar(百度学术,中国)
Baidu Baike(百度百科,中国)
ICI(哥白尼期刊数据库,波兰)
EuroPub(欧洲学术出版数据库,英国)
MDPI scilit(科学与学术数据库,瑞士)
Crossref(交叉引用,美国)
Semantic Scholar(语义学术,美国)
OpenAlex(全球开源学术平台,加拿大)
ACADEMIA.EDU(学术界,美国)
OUCI(开放乌克兰科学,乌克兰)
WorldCat(世界编目数据库,美国)
Scite(智能引文分析数据库,美国)
The Lens(透镜学术,澳大利亚)
OpenAIRE(开放学术发现门户,欧洲)
Google Scholar(谷歌学术,美国)
DOI(数字对象唯一标识符,英国)
Portico(数字存储库,美国)
J-Gate(开放获取期刊门户,印度)
ResearchGate(研究之门,德国)
Research Commons(科睿唯安,美国)
Socolar(开放获取资源检索,中国,更新中)
Sci Online(科学在线,中国澳门)
OALib(开放存取资源图书馆,美国)
EZB(电子期刊图书馆,德国,申请中)
Road(开放科学学术资源,法国)
ISI(国际科学索引平台,阿联酋迪拜)
ASCI(亚洲科学引文索引,美国)
ESJI(欧亚科学期刊索引,哈萨克斯坦)
ResearchBib(研究者索引,日本)
SPI-Hub™(范德比尔特大学,美国)
SJIF(科学期刊影响因子,印度)
RJIF(研究期刊影响因子)
COSMOS(期刊评价指标,印度)
LivRe!(开放期刊门户,巴西)
KIND CONGRESS(阿塞拜疆)
Journament(质量评估与索引)
IP Indexing(ip索引)
Magzter(跨平台数字期刊,美国)
SlideShare(知识共享平台,美国)
SCRIBD(在线图书馆,美国)
Yahoo! Search(雅虎,美国)
Microsoft Bing(微软学术,美国)
LibKey(学术文献快捷获取工具)
R Discovery(研究者发现平台,印度)
Enterscholar(恩特学术)

规划申请

SinoMed 中国生物医学文献服务系统
EBSCO 学术文献数据库(美国)

CABI 国际农业与生物科学中心(英国)
RePEc 经济研究文献数据库(美国)
OAJ 全球OA期刊索引(中国)
DOAJ 开放获取期刊目录(瑞典)
PubMed 医学文摘数据库(美国)
PubMed Central 医学全文数据(美国)
Scopus 爱思唯尔·斯高帕斯(荷兰)
EMBASE 爱思唯尔·医学文摘(荷兰)
ProQuest 科睿唯安(美国)
Research4Life 世界卫生组织数据库

Editing and Publishing
Quest Press Limited
Address
Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
https://zwlc.scionline2025.com
  往期阅览 · All Issues-> 2025年 · 2025  
中外临床医学2025年第1卷第2期第58-62页,pISSN 3080-7611、eISSN 3080-762X 发布者:Quest Press 发布日期:2025/10/19
Open Access 浏览337

 

妊娠期高血压疾病的临床分级管理


李媛媛

湖北省襄阳市谷城县人民医院妇产科,湖北襄阳,441700

摘要:妊娠期高血压疾病(hypertensive disorders of pregnancy, HDP)是妊娠中晚期常见的严重并发症,以高血压、蛋白尿及多器官功能损害为主要特征,是导致孕产妇和围产儿死亡的重要原因之一。目的 深入探讨妊娠期高血压疾病(HDP)临床分级管理模式在基层医疗机构的适用性及母婴结局改善效果。方法 采用回顾性队列研究设计,分析纳入2023年1月—2024年6月某基层医院收治的200例HDP 患者,根据《妊娠期高血压疾病诊治指南》进行精准分级,分为妊娠期高血压(56 例)、轻度子痫前期(78 例)、重度子痫前期(66 例),采用结构化分级管理模式(包括风险分层、动态血压监测、对症解痉降压、适时终止妊娠等),对比三组母婴并发症发生率及管理前后子痫发生率的差异,比较母婴结局。结果 重度子痫前期组剖宫产率(84.8%)、新生儿窒息率(19.7%)显著高于妊娠期高血压组(21.4%、3.6%)和轻度子痫前期组(42.3%、7.7%)(P< 0.01)。分级管理后,重度子痫前期患者子痫发生率由历史数据的12.5%降至3.0%。结论 临床分级管理通过资源优化配置和差异化干预,显著降低重度子痫患者及新生儿窒息风险,可优化HDP 患者母婴结局,是基层医院提升妊娠期高血压疾病管理效能的科学路径,适合基层医院推广。

关健词:妊娠期高血压疾病;临床分级管理;母婴结局;子痫前期;基层医院
Clinical Grading Management of Hypertensive Disorders in Pregnancy

Yuanyuan Li

Obstetrics and Gynecology Department of Gucheng County People’s Hospital, Xiangyang, Hubei 441700 , China

Abstract:Hypertensive disorders complicating pregnancy are common severe complications in the middle and late stages ofpregnancy, characterized by hypertension proteinuria, and multi-organ dysfunction, and are one of the important causes of maternaland perinatal deaths. Objective To further explore the applicability of the clinical management model of hypertensivedisorders complicating pregnancy (HDP) in primary medical institutions and the effect of improving maternal and infant outcomes.Methods A retrospective cohort study design was to analyze 200 cases of HDP patients admitted to a primary hospitalfrom January 2023 to June 2024. According to the“ Gu for the Diagnosis and Treatment of Hypertensive Disorders ComplicatingPregnancy”, the patients were accurately graded into gestational hypertension (56 cases), preeclampsia (78 cases), and severepreeclampsia (66 cases). A structured graded management model (including risk stratification, dynamic pressure monitoring,symptomatic spasmolysis and blood pressure reduction, and timely termination of pregnancy, etc.) was used to compare the incidenceof maternal and infant complications and the of eclampsia incidence before and after management among the three groups,and to compare maternal and infant outcomes. Results The rate of cesarean section (848%) and the rate of neonatal asphyxia(19.7%) in the severe preeclampsia group were significantly higher than those in the gestational hypertension (21.4%, 3.6%) andthe mild preeclampsia group (42.3%, 7.7%) (P<.01). After graded management, the incidence of eclampsia in severe preeclampsiapatients was reduced from 12.5% in the historical to 3.0%. Conclusion Clinical graded management has significantly reducedthe risk of severe preeclampsia patients and neonatal asphyxia through resource optimization and intervention, which canoptimize the maternal and infant outcomes of HDP patients, which is a scientific path to improve the management efficiency ofhypertensive disorders complicating pregnancy in primary hospitals, is suitable for the promotion of primary hospitals.


Keywords : gestational hypertension disease; Clinical grading management; Maternal and infant outcomes; Preeclampsia; primary-level hospital
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.

 
Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
关于 Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Joining the Editorial Board, Associate Editors, Peer Reviewers, and Editor-in-Chief
加入编委、副主编、同行评审专家及主编
Quest Press
Bridging Research to a Global Stage.
academia
© 2025-2026 Quest Press Ltd.
Address: Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Tel: +853 6881 9699 / Email: QuestPress@hotmail.com
The QUEST PRESS publishes articles under the following open access license.
Quest Press
is a member of the following organizations.